Serum levels of soluble interleukin-2 receptor (sIL2-R) were studied i
n patients with or without Sjogren's syndrome (SS). The mean sIL2-R le
vel was significantly higher (P < 0.0001) in those with autoimmune dis
eases, whether with or without SS, than in healthy people. The serum l
evel of sIL2-R did not help to distinguish primary from secondary SS,
or the absence of this syndrome in patients with autoimmune diseases.
We found a correlation between the sIL2-R level and the presence of SS
-A and SS-B antibodies or antinuclear antibody levels, and no correlat
ion with other serological and clinical markers. Salivary gland anomal
ies were always accompanied by high sIL2-R levels, but there was no co
rrelation between sIL2-R levels and degree of glandular lesion. Routin
e determination of sIL2-R in patients with dry syndrome is likely to p
rove useful for ruling out SS without resorting to invasive testing.